Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of human trial design

E Buiatti1

  • 1Epidemiology Unit, Centre for Cancer Study and Prevention, Florence, Italy.

IARC Scientific Publications
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Designing effective chemopreventive trials requires careful consideration of agent selection, dosage, population, and trial design. Key factors include run-in phases, compliance monitoring, and adequate follow-up for valid cancer prevention results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women changing the times:.

New solutions : a journal of environmental and occupational health policy : NS·2012
Same author

Incidence rates of surgically treated idiopathic carpal tunnel syndrome in blue- and white-collar workers and housewives in Tuscany, Italy.

Occupational and environmental medicine·2009
Same author

National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.

Diabetes, obesity & metabolism·2007
Same author

Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.

Diabetes/metabolism research and reviews·2007
Same author

Use and efficacy of abciximab in an unselected population with acute myocardial infarction treated with primary angioplasty: data from AMI-Florence registry.

Atherosclerosis·2006
Same author

Hospital care of patients with ST-elevation myocardial infarction in four different European regions. Data from four regional myocardial infarction registries in Berlin, Dijon, Florence, and Tartu.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2005

Area of Science:

  • Oncology
  • Clinical Trial Design
  • Pharmacology

Background:

  • Randomized trials are the gold standard for evaluating chemopreventive agents.
  • Specific design challenges exist for chemoprevention studies compared to general clinical trials.

Purpose of the Study:

  • To outline critical design considerations for randomized chemoprevention trials.
  • To provide solutions for specific issues in evaluating chemopreventive agents.

Main Methods:

  • Discusses agent selection, dose, formulation, and population choice.
  • Explores trial designs (e.g., factorial), run-in phases, and pilot studies.
  • Highlights the importance of compliance monitoring, sample size, follow-up duration, and endpoint validation.

Related Experiment Videos

Main Results:

  • Agent mechanism, disease natural history, and dose-response relationships influence design choices.
  • Run-in phases can improve compliance and feasibility but may bias results.
  • Control group exposure changes and side effects necessitate careful monitoring to maintain study power.

Conclusions:

  • Optimizing chemoprevention trial design is crucial for valid and relevant cancer prevention findings.
  • Careful planning regarding population, dosage, intervention length, and monitoring is essential.
  • Validated endpoints and sufficient follow-up ensure the reliability and applicability of results.